Advertisement
Screener

SHENGTAI PHARMACEUTICAL, INC. Operating Cash Flow

SHENGTAI PHARMACEUTICAL, INC. Operating Cash Flow

SHENGTAI PHARMACEUTICAL, INC. reported Operating Cash Flow of -$4.40 million for the 9-month period ending 2013-03-31, per its 10-Q filed 2013-05-15.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2013-05-15

  • SHENGTAI PHARMACEUTICAL, INC. net cash provided by (used in) operating activities for the quarter ending 2013-03-31 was -$5.68M.
  • SHENGTAI PHARMACEUTICAL, INC. net cash provided by (used in) operating activities for the quarter ending 2012-12-31 was -$3.59M, a 177.82% decline year-over-year.
  • SHENGTAI PHARMACEUTICAL, INC. net cash provided by (used in) operating activities for the quarter ending 2012-09-30 was $4.87M.
  • SHENGTAI PHARMACEUTICAL, INC. net cash provided by (used in) operating activities for the quarter ending 2012-06-30 was -$13.35M, a 634.20% decline year-over-year.
  • SHENGTAI PHARMACEUTICAL, INC. net cash provided by (used in) operating activities for fiscal 2012 was -$23.74M, a 568.24% decline from fiscal 2011.
  • SHENGTAI PHARMACEUTICAL, INC. net cash provided by (used in) operating activities for fiscal 2011 was $5.07M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 month
2013-03-31-$5.68M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-15
-$9.27M
derived: sum of 2 quarters · filed 2013-05-15
-$4.40M
10-Q · filed 2013-05-15
-$17.74M
derived: sum of 4 quarters · filed 2013-05-15
2012-12-31-$3.59M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-14
$1.29M
10-Q · filed 2013-02-14
-$12.06M
derived: sum of 3 quarters · filed 2013-02-14
-$12.91M
derived: sum of 4 quarters · filed 2013-05-15
2012-09-30$4.87M
10-Q · filed 2012-11-14
-$8.48M
derived: sum of 2 quarters · filed 2012-11-14
-$9.33M
derived: sum of 3 quarters · filed 2013-05-15
-$4.72M
derived: sum of 4 quarters · filed 2013-05-15
2012-06-30-$13.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-09-28
-$14.20M
derived: sum of 2 quarters · filed 2013-05-15
-$9.59M
derived: sum of 3 quarters · filed 2013-05-15
-$23.74M
10-K · filed 2012-09-28
2012-03-31-$851.94K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-15
$3.76M
derived: sum of 2 quarters · filed 2013-05-15
-$10.39M
10-Q · filed 2013-05-15
-$7.89M
derived: sum of 4 quarters · filed 2013-05-15
2011-12-31$4.61M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-14
-$9.54M
10-Q · filed 2013-02-14
-$7.04M
derived: sum of 3 quarters · filed 2013-02-14
-$9.59M
derived: sum of 4 quarters · filed 2013-02-14
2011-09-30-$14.15M
10-Q · filed 2012-11-14
-$11.65M
derived: sum of 2 quarters · filed 2012-11-14
-$14.20M
derived: sum of 3 quarters · filed 2012-11-14
-$13.55M
derived: sum of 4 quarters · filed 2012-11-14
2011-06-30$2.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-09-28
-$50.62K
derived: sum of 2 quarters · filed 2012-09-28
$599.59K
derived: sum of 3 quarters · filed 2012-09-28
$5.07M
10-K · filed 2012-09-28
2011-03-31-$2.55M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-15
-$1.90M
derived: sum of 2 quarters · filed 2012-05-15
$2.57M
10-Q · filed 2012-05-15
2010-12-31$650.21K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-14
$5.12M
10-Q · filed 2012-02-14
2010-09-30$4.47M
10-Q · filed 2011-11-14